Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIL Therapy for Disseminated Melanoma
NCT00937625Phase 2Completed
- Start
- Jun 2009
- Primary completion
- Jan 2015
- Modality
- Monoclonal Antibodies, Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous tumor-infiltrating lymphocytes in melanoma. Started Jun 2009; status: completed.
02
Drugs
autologous tumor-infiltrating lymphocytes
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00937625.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00937625.